Y-mabs enters into partnership with Uruguayan firm to launch cancer drugs in South America

Danish biotech firm Y-mabs Therapeutics has closed a Latin American distribution contract for the company's two cancer drugs.
Photo: Kelly Davidson Photography
Photo: Kelly Davidson Photography
BY ALBERT RØNNING-ANDERSSON AND ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT

Y-mabs Therapeutics has found distribution partners in South America for its two pediatric cancer drugs.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading